Rating Change
Wells Fargo reiterated its Overweight rating on Globus Medical, Inc. (NYSE:GMED) on August 07, 2026.
reiterateNYSE:GMED
Wells Fargo Reiterates Overweight Rating on Globus Medical, Inc. (GMED)
Wells Fargo reiterated its Overweight rating on Globus Medical, Inc. (NYSE:GMED) on August 07, 2026.
At publication ·
What changed
Globus Medical, Inc. (NYSE:GMED) · reiterate
- Firm
- Wells Fargo
- Rating
- Overweight to Overweight
- Price at event
- $82.35
- Market capitalization
- $11.9B
At a glance
Key takeaways
- Wells Fargo reiterated an Overweight rating on Globus Medical (GMED) on August 7, 2026, with the stock trading at $82.35 and a market capitalization of $11.9 billion.
Market Context
Globus Medical, Inc. operates in the Healthcare sector. The stock currently trades at $82.35 with a market capitalization of $11.9B. The stock has gained 55.9% over the past 52 weeks.
Analyst coverage from Wells Fargo provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Globus Medical, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Globus Medical, Inc.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 07, 2026 | Wells Fargo | Overweight | N/A |
| Jul 28, 2026 | UBS | Neutral | N/A |
| Jul 16, 2026 | Truist Securities | Buy | N/A |
| Jul 13, 2026 | RBC Capital | Outperform | N/A |
| Jul 09, 2026 | BMO Capital | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View GMED Stock Page
Frequently Asked Questions
What does the Overweight rating mean for GMED?
A rating of Overweight from Wells Fargo reflects the analyst's outlook on Globus Medical, Inc. (NYSE:GMED). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the GMED forecast page.